Literature DB >> 3639739

A human auto-immune antibody specifically recognizing initiator methionine tRNA from yeast and higher eucaryotes.

J Sri-Widada, H Graafland, R Dietz, C Brunel, G Cathala, P Jeanteur.   

Abstract

Analysis of sera from 168 patients with autoimmune disorders revealed that one patient with Sjôgren's syndrome produced antibodies against deproteinized initiator methionine tRNA in addition to those against La protein. This anti-tRNAimet recognizes also tRNAimet from yeast but not from Phaseolus vulgaris chloroplasts (bean) or E. coli. It appears therefore that the epitope could be located in the TF loop in which an A residue in position 60 and the AUCG sequence are the only common features in yeast and human tRNAimet.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3639739     DOI: 10.1016/s0006-291x(86)80109-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Systemic lupus erythmatosus associated with autoimmune hepatitis two cases with novel autoantibodies to transfer RNA-related antigens.

Authors:  T Satoh; M Hirakata; T Yoshida; M Matsumura; K Miyachi; T Mimori; M Akizuki
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

2.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

3.  Anti-transfer RNA antibodies in two patients with pulmonary fibrosis, Raynaud's phenomenon and polyarthritis.

Authors:  Y Ohosone; M Matsumura; J Chiba; S Nagaoka; Y Matsuoka; S Irimajiri; T Mimori
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Autoimmune epitopes in messenger RNA.

Authors:  Barbara D Lipes; Jack D Keene
Journal:  RNA       Date:  2002-06       Impact factor: 4.942

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.